Potassium-Lowering Effect of Mineralocorticoid Therapy in Patients Undergoing Hemodialysis
Potassium-Lowering Effect of Mineralocorticoid Therapy in Patients Undergoing Hemodialysis
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
The present study was conducted to examine potassium lowering effect of exogenous mineralocorticoid (fludrocortisone acetate; FCA) administration to the patients with chronic renal failure undergoing hemodialysis. Fifteen patients on hemodialysis receiving FCA with its dosage gradually increased from 0 to 0.20 mg/day were observed for five successi...
Alternative Titles
Full title
Potassium-Lowering Effect of Mineralocorticoid Therapy in Patients Undergoing Hemodialysis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_12372940
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_12372940
Other Identifiers
ISSN
1660-8151
E-ISSN
2235-3186
DOI
10.1159/000064116
